ArticleClinical kidney journal2026
Disasters and hazard exposure in end-stage kidney disease: a scoping review of patient outcomes.
Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The vulnerability of patients with end-stage kidney disease (ESKD) to natural and societal hazards is acknowledged. However, evidence remains dispersed across various hazards, settings, and sample sizes. We aimed to synthesize empirical literature analyzing the impact of hazard exposure on patient outcomes. Methods: This was a scoping review conducted using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis) guidelines of contemporary literature (2000 onwards) that examined medical or psychosocial outcomes among patients with ESKD needing kidney replacement therapy. Results: Of the 10 040 titles and abstracts screened, 30 studies from 10 countries/regions met our inclusion criteria. Hazards assessed included inclement weather ( Conclusion: Our review consolidates findings across multiple studies and highlights the profound vulnerability of ESKD patients to hazards. Evidence gaps are highlighted to guide future research and policy efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.